Meritage Group’s Steris STE Stock Holding History

Meritage Group’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,078	Closed	-$206K	–	65
2023 Q1	$206K	Sell	1,078 -150	-12%	-$29K	0.01%	48
2022 Q4	$227K	Buy	+1,228	New	+$216K	0.01%	28

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meritage Group's STE Position: Q2 2023 in Review

Meritage Group sold out of Steris (STE) in Q2 2023, closing a stake of 1,078 shares — an estimated $206K sold.

Meritage Group first reported a position in STE in Q4 2022 and held it in 2 quarters. The position peaked at $227K in Q4 2022. 657 funds tracked by Wall St. Rank hold STE as of Q2 2023.

Meritage Group reported no remaining Steris position as of Q2 2023 after selling out during the quarter.
Meritage Group sold 1,078 Steris shares in Q2 2023, an estimated $206K.
Meritage Group first reported a position in Steris in Q4 2022 and held it in 2 quarters.
Meritage Group's Steris position peaked at $227K in Q4 2022.
657 funds tracked by Wall St. Rank held Steris as of Q2 2023.

Based on Meritage Group's 13F filing for Q2 2023, filed 11 Aug 2023.